跳至主要内容
临床试验/NCT00518414
NCT00518414已完成不适用

The Evaluation of Cow Milk-Based Formulas - Study A

Mead Johnson Nutrition9 个研究点 分布在 1 个国家目标入组 136 人开始时间: 2007年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
136
试验地点
9
主要终点
Red Blood Cell (RBC) ARA and DHA

研究概览

简要总结

Infants will be fed infant formula and blood drawn to measure fatty acid levels in the blood.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
10 Days 至 18 Days(Child)
性别
All
接受健康志愿者
是

入选标准

  • •Healthy, term infant
  • •10 to 18 days of age

排除标准

  • •Breast fed infants
  • •Infants with formula intolerance

研究组 & 干预措施

Marketed infant formula with DHA and ARA

Active Comparator

Marketed milk-based infant formula containing docosahexaenoic acid (DHA) and arachidonic acid (ARA)

干预措施: Marketed infant formula with DHA and ARA (Other)

Milk-based infant formula with DHA and ARA

Experimental

Experimental milk-based infant formula containing docosahexaenoic acid (DHA) and arachidonic acid (ARA)

干预措施: Milk-based infant formula with DHA and ARA (Other)

Milk-based formula with DHA, ARA, prebiotics

Experimental

Experimental milk-based infant formula containing docosahexaenoic acid (DHA) and arachidonic acid (ARA) and prebiotic blend

干预措施: Milk-based formula with DHA, ARA, prebiotics (Other)

结局指标

主要结局

Red Blood Cell (RBC) ARA and DHA

时间窗: 120 Days of age

次要结局

  • Phospholipid fatty acids, tolerance(120 Days of age)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验